| Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment P Li, JX Shan, XH Chen, D Zhang, LP Su, XY Huang, BQ Yu, QM Zhi, ... Cell research 25 (5), 588-603, 2015 | 138 | 2015 |
| CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2 D Bedognetti, TL Spivey, Y Zhao, L Uccellini, S Tomei, ME Dudley, ... British journal of cancer 109 (9), 2412-2423, 2013 | 129 | 2013 |
| Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ... Oncoimmunology 6 (2), e1253654, 2017 | 116 | 2017 |
| Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients ML Ascierto, MO Idowu, Y Zhao, H Khalak, KK Payne, XY Wang, ... Journal of translational medicine 11 (1), 1-11, 2013 | 85 | 2013 |
| IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes D Murtas, D Maric, V De Giorgi, J Reinboth, A Worschech, P Fetsch, ... British journal of cancer 109 (1), 76-82, 2013 | 54 | 2013 |
| Detection of the BRAF V600E mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve … I Marchetti, G Iervasi, CM Mazzanti, F Lessi, S Tomei, AG Naccarato, ... Thyroid 22 (3), 292-298, 2012 | 54 | 2012 |
| The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management F Panebianco, C Mazzanti, S Tomei, P Aretini, S Franceschi, F Lessi, ... Bmc Cancer 15 (1), 1-11, 2015 | 45 | 2015 |
| Melanoma NOS1 expression promotes dysfunctional IFN signaling Q Liu, S Tomei, ML Ascierto, V De Giorgi, D Bedognetti, C Dai, L Uccellini, ... The Journal of clinical investigation 124 (5), 2147-2159, 2014 | 41 | 2014 |
| VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma F Lessi, CM Mazzanti, S Tomei, C Di Cristofano, A Minervini, M Menicagli, ... Medical Oncology 31 (3), 1-7, 2014 | 39 | 2014 |
| IRF5 gene polymorphisms in melanoma L Uccellini, V De Giorgi, Y Zhao, B Tumaini, N Erdenebileg, ME Dudley, ... Journal of translational medicine 10 (1), 1-8, 2012 | 38 | 2012 |
| The immune-related role of BRAF in melanoma S Tomei, D Bedognetti, V De Giorgi, M Sommariva, S Civini, J Reinboth, ... Molecular oncology 9 (1), 93-104, 2015 | 33 | 2015 |
| SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools-a compass in the land of biomarker discovery D Bedognetti, JM Balwit, E Wang, ML Disis, CM Britten, LG Delogu, ... Journal of translational medicine 9 (1), 1-21, 2011 | 32 | 2011 |
| The stable traits of melanoma genetics: an alternate approach to target discovery TL Spivey, V De Giorgi, Y Zhao, D Bedognetti, Z Pos, Q Liu, S Tomei, ... BMC genomics 13 (1), 1-11, 2012 | 31 | 2012 |
| Future perspectives in melanoma research: meeting report from the" Melanoma Bridge", Napoli, December 5th-8th 2013 PA Ascierto, AM Grimaldi, AC Anderson, C Bifulco, A Cochran, C Garbe, ... Journal of translational medicine 12 (1), 1-29, 2014 | 30* | 2014 |
| Obesity susceptibility loci in Qataris, a highly consanguineous Arabian population S Tomei, R Mamtani, R Al Ali, N Elkum, M Abdulmalik, A Ismail, ... Journal of Translational Medicine 13 (1), 1-8, 2015 | 25 | 2015 |
| A molecular computational model improves the preoperative diagnosis of thyroid nodules S Tomei, I Marchetti, K Zavaglia, F Lessi, A Apollo, P Aretini, G Di Coscio, ... BMC cancer 12 (1), 1-10, 2012 | 24 | 2012 |
| Temple-baraitser syndrome and zimmermann-laband syndrome: one clinical entity? A Mégarbané, R Al-Ali, N Choucair, M Lek, E Wang, M Ladjimi, CM Rose, ... BMC Medical Genetics 17 (1), 1-11, 2016 | 23 | 2016 |
| c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules S Tomei, C Mazzanti, I Marchetti, L Rossi, K Zavaglia, F Lessi, A Apollo, ... Journal of translational medicine 10 (1), 1-9, 2012 | 22 | 2012 |
| Cutaneous melanoma classification: the importance of high-throughput genomic technologies C Scatena, D Murtas, S Tomei Frontiers in oncology, 1313, 2021 | 20 | 2021 |
| Common pathways to tumor rejection E Wang, D Bedognetti, S Tomei, FM Marincola Annals of the New York Academy of Sciences 1284 (1), 75-79, 2013 | 20 | 2013 |
